View in EDS PDF Full Text

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Saved in:
Bibliographic Details
Title: Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Authors: Fontán-Vela M; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; Public Health and Epidemiology research group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain., Kissling E; Epiconcept, Paris, France., Nicolay N; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Braeye T; Sciensano, Elsene, Belgium., Van Evercooren I; Sciensano, Elsene, Belgium., Holm Hansen C; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Emborg HD; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark., Fabiani M; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., Mateo-Urdiales A; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy., AlKerwi A; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Schmitz S; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg., Castilla J; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., Martínez-Baz I; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain., de Gier B; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Hahné S; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Meijerink H; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Starrfelt J; Norwegian Institute of Public Health (NIPH), Oslo, Norway., Nunes B; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Caetano C; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal., Derrough T; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden., Nardone A; Epiconcept, Paris, France., Monge S; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; CIBER on Infectious Diseases (CIBERINFEC), Madrid, Spain.
Corporate Authors: VEBIS-Lot4 working group; The members of the VEBIS-Lot4 working group are listed under Collaborators., VEBIS-Lot 4 working group
Source: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Jan; Vol. 29 (1).
Publication Type: Journal Article
Journal Info: Publisher: European Centre for Disease Prevention and Control (ECDC) Country of Publication: Sweden NLM ID: 100887452 Publication Model: Print Cited Medium: Internet ISSN: 1560-7917 (Electronic) Linking ISSN: 1025496X NLM ISO Abbreviation: Euro Surveill Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38179626
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fontán-Vela+M%22">Fontán-Vela M</searchLink>; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; Public Health and Epidemiology research group, School of Medicine and Health Sciences, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Kissling+E%22">Kissling E</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Nicolay+N%22">Nicolay N</searchLink>; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Braeye+T%22">Braeye T</searchLink>; Sciensano, Elsene, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+Evercooren+I%22">Van Evercooren I</searchLink>; Sciensano, Elsene, Belgium.<br /><searchLink fieldCode="AU" term="%22Holm+Hansen+C%22">Holm Hansen C</searchLink>; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Emborg+HD%22">Emborg HD</searchLink>; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut (SSI), Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Fabiani+M%22">Fabiani M</searchLink>; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Mateo-Urdiales+A%22">Mateo-Urdiales A</searchLink>; Infectious Diseases Department, Istituto Superiore di Sanità, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22AlKerwi+A%22">AlKerwi A</searchLink>; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Schmitz+S%22">Schmitz S</searchLink>; Ministry of Health, Directorate of Health, Service epidemiology and statistics, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Castilla+J%22">Castilla J</searchLink>; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Baz+I%22">Martínez-Baz I</searchLink>; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22de+Gier+B%22">de Gier B</searchLink>; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hahné+S%22">Hahné S</searchLink>; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Meijerink+H%22">Meijerink H</searchLink>; Norwegian Institute of Public Health (NIPH), Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Starrfelt+J%22">Starrfelt J</searchLink>; Norwegian Institute of Public Health (NIPH), Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Nunes+B%22">Nunes B</searchLink>; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Caetano+C%22">Caetano C</searchLink>; Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Departamento de Epidemiologia, Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Derrough+T%22">Derrough T</searchLink>; Vaccine Preventable Diseases and Immunisation, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Nardone+A%22">Nardone A</searchLink>; Epiconcept, Paris, France.<br /><searchLink fieldCode="AU" term="%22Monge+S%22">Monge S</searchLink>; National Centre of Epidemiology, Carlos III National Health Institute (ISCIII), Madrid, Spain.; CIBER on Infectious Diseases (CIBERINFEC), Madrid, Spain.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22VEBIS-Lot4+working+group%22">VEBIS-Lot4 working group</searchLink>; The members of the VEBIS-Lot4 working group are listed under Collaborators.<br /><searchLink fieldCode="CA" term="%22VEBIS-Lot+4+working+group%22">VEBIS-Lot 4 working group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100887452%22">Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</searchLink> [Euro Surveill] 2024 Jan; Vol. 29 (1).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Centre+for+Disease+Prevention+and+Control+%28ECDC%29%22">European Centre for Disease Prevention and Control (ECDC) </searchLink><i>Country of Publication: </i>Sweden <i>NLM ID: </i>100887452 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1560-7917 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221025496X%22">1025496X </searchLink><i>NLM ISO Abbreviation: </i>Euro Surveill <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38179626
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2807/1560-7917.ES.2024.29.1.2300670
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fontán-Vela M
      – PersonEntity:
          Name:
            NameFull: Kissling E
      – PersonEntity:
          Name:
            NameFull: Nicolay N
      – PersonEntity:
          Name:
            NameFull: Braeye T
      – PersonEntity:
          Name:
            NameFull: Van Evercooren I
      – PersonEntity:
          Name:
            NameFull: Holm Hansen C
      – PersonEntity:
          Name:
            NameFull: Emborg HD
      – PersonEntity:
          Name:
            NameFull: Fabiani M
      – PersonEntity:
          Name:
            NameFull: Mateo-Urdiales A
      – PersonEntity:
          Name:
            NameFull: AlKerwi A
      – PersonEntity:
          Name:
            NameFull: Schmitz S
      – PersonEntity:
          Name:
            NameFull: Castilla J
      – PersonEntity:
          Name:
            NameFull: Martínez-Baz I
      – PersonEntity:
          Name:
            NameFull: de Gier B
      – PersonEntity:
          Name:
            NameFull: Hahné S
      – PersonEntity:
          Name:
            NameFull: Meijerink H
      – PersonEntity:
          Name:
            NameFull: Starrfelt J
      – PersonEntity:
          Name:
            NameFull: Nunes B
      – PersonEntity:
          Name:
            NameFull: Caetano C
      – PersonEntity:
          Name:
            NameFull: Derrough T
      – PersonEntity:
          Name:
            NameFull: Nardone A
      – PersonEntity:
          Name:
            NameFull: Monge S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1560-7917
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
              Type: main
ResultId 1